Tempest Therapeutics (TPST) Q4 2023 Earnings

19MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.64
-0.54
-0.44
-0.34

Details

Expected EPS
-0.39
Actual EPS
-0.34
Surprise EPS
0.05
Surprise Percent
+12.82%

Description

Tempest Therapeutics (TPST) has reported earnings of -0.34 per share for Q4 2023.

0 Comments

Share your thoughts